Innovations in ways to improve options and outcomes in patients with Varicose Veins continue to develop. Varithena® (polidocanol injectable foam) 1% is a prescription medicine used to treat varicose veins caused by problems with the great saphenous vein (GSV) and other related veins in the leg’s GSV system. Varithena® helps improve the symptoms of heaviness, achiness, swelling, throbbing, itching related to or caused by varicose veins, and the appearance of varicose veins. Treatment is a nonsurgical procedure (no incision is required). Treatment usually takes less than one hour and patients may resume light activities as quickly as the same day of treatment. Having participated in the Varithena clinical trials at INOVIA® Vein Specialty Center, we are pleased to see this new innovation now on the market and available to patients.